Education
About Us
Working with TipRanks
Follow Us
Alzamend Neuro (ALZN)
NASDAQ:ALZN
Al001, Lithium Carbonate Capsule
Pharmacokinetics, Neurology
Phase I
Active Not Recruiting
A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Healthy Adult Subjects
Mar 19, 2025
―
Alzn002 (Autologous Dcs Pulsed With E22w Mutant Peptide).
Alzheimer Disease
Phase I/II
Active Not Recruiting
Study in Subjects With Mild-to-Moderate Alzheimer's Dementia
Feb 22, 2023
―
Al001
Alzheimer's Disease, Healthy Non-Elderly And Elderly Adults
Phase I/II
Completed
Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult Subjects
Apr 27, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Alzamend Neuro (ALZN) have in its pipeline
ALZN is currently developing the following drugs: Al001, Lithium Carbonate Capsule, Alzn002 (Autologous Dcs Pulsed With E22w Mutant Peptide)., Al001. These drug candidates are in various stages of clinical development as the company works toward FDA approval.